| Authors: |
Devlin MJ; Barts Cancer Institute, Queen Mary University of London, London, United Kingdom.; Department of Medical Oncology, St Bartholomew's Hospital, London, United Kingdom., Miller R; Department of Medical Oncology, St Bartholomew's Hospital, London, United Kingdom.; Department of Medical Oncology, University College London Hospital, London, United Kingdom., Laforets F; Barts Cancer Institute, Queen Mary University of London, London, United Kingdom., Kotantaki P; Barts Cancer Institute, Queen Mary University of London, London, United Kingdom., Garsed DW; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Kristeleit R; Medical Oncology Department, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom., Bowtell DD; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., McDermott J; Department of Surgery and Cancer, Imperial College London, London, United Kingdom., Maniati E; Barts Cancer Institute, Queen Mary University of London, London, United Kingdom., Balkwill FR; Barts Cancer Institute, Queen Mary University of London, London, United Kingdom. |